These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36550997)

  • 1. Bioprocess Economic Modeling: Decision Support Tools for the Development of Stem Cell Therapy Products.
    Salvador WOS; Ribeiro IAB; Nogueira DES; Ferreira FC; Cabral JMS; Rodrigues CAV
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36550997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidics for cell factory and bioprocess development.
    Bjork SM; Joensson HN
    Curr Opin Biotechnol; 2019 Feb; 55():95-102. PubMed ID: 30236890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bringing Stem Cell-Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost-Effectiveness Analysis.
    Bandeiras C; Cabral JMS; Gabbay RA; Finkelstein SN; Ferreira FC
    Biotechnol J; 2019 Aug; 14(8):e1800563. PubMed ID: 31127682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing and understanding the robustness of bioprocesses.
    Becker L; Sturm J; Eiden F; Holtmann D
    Trends Biotechnol; 2023 Aug; 41(8):1013-1026. PubMed ID: 36959084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization.
    Silva MM; Rodrigues AF; Correia C; Sousa MF; Brito C; Coroadinha AS; Serra M; Alves PM
    Stem Cells Transl Med; 2015 Jul; 4(7):731-42. PubMed ID: 25979863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
    Jenkins MJ; Farid SS
    Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico regenerative medicine: how computational tools allow regulatory and financial challenges to be addressed in a volatile market.
    Geris L; Guyot Y; Schrooten J; Papantoniou I
    Interface Focus; 2016 Apr; 6(2):20150105. PubMed ID: 27051516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioprocess TEA calculator: An online technoeconomic analysis tool to evaluate the commercial competitiveness of potential bioprocesses.
    Lynch MD
    Metab Eng; 2021 May; 65():42-51. PubMed ID: 33711381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies.
    Simaria AS; Hassan S; Varadaraju H; Rowley J; Warren K; Vanek P; Farid SS
    Biotechnol Bioeng; 2014 Jan; 111(1):69-83. PubMed ID: 23893544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioreactors and bioseparation.
    Zhang S; Cao X; Chu J; Qian J; Zhuang Y
    Adv Biochem Eng Biotechnol; 2010; 122():105-50. PubMed ID: 20396995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of agent-based system for bioprocess description and process improvement.
    Gao Y; Kipling K; Glassey J; Willis M; Montague G; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):706-16. PubMed ID: 20014420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell biomanufacturing under uncertainty: A case study in optimizing red blood cell production.
    Misener R; Allenby MC; Fuentes-Garí M; Gupta K; Wiggins T; Panoskaltsis N; Pistikopoulos EN; Mantalaris A
    AIChE J; 2018 Aug; 64(8):3011-3022. PubMed ID: 30166646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical Process Optimization with Simulation and Scheduling Tools.
    Petrides D; Carmichael D; Siletti C; Koulouris A
    Bioengineering (Basel); 2014 Sep; 1(4):154-187. PubMed ID: 28955023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of experiments and design space approaches in the pharmaceutical bioprocess optimization.
    Kasemiire A; Avohou HT; De Bleye C; Sacre PY; Dumont E; Hubert P; Ziemons E
    Eur J Pharm Biopharm; 2021 Sep; 166():144-154. PubMed ID: 34147574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Raman Spectroscopy and Univariate Modelling As a Process Analytical Technology for Cell Therapy Bioprocessing.
    Baradez MO; Biziato D; Hassan E; Marshall D
    Front Med (Lausanne); 2018; 5():47. PubMed ID: 29556497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.